Vicapsys Life Sciences, Inc. logo

Vicapsys Life Sciences, Inc.

OTC:VICP

Overview | Financials
Company Name Vicapsys Life Sciences, Inc.
Symbol VICP
Currency USD
Price 2
Market Cap 62,377,000
Dividend Yield 0%
52-week-range 1 - 3
Industry Biotechnology
Sector Healthcare
CEO Mr. Federico Pier
Website https://vicapsys.com

An error occurred while fetching data.

About Vicapsys Life Sciences, Inc.

Vicapsys Life Sciences, Inc. focuses on the development and commercialization of VICAPSYN proprietary product. Its product is applied to transplantation therapies and related stem-cell applications in the transplantation field. The company is also developing VYBRIN, a product based on CXCL12 for prevention of post-surgical adhesions in abdominal surgery, coating of

Related Stocks

Oncotelic Therapeutics, Inc. logo

Oncotelic Therapeutics, Inc.

OTLC

0.037 USD

Medicine Man Technologies, Inc. logo

Medicine Man Technologies, Inc.

SHWZ

0.61 USD

Allied Corp. logo

Allied Corp.

ALID

0.101 USD

Charlotte's Web Holdings, Inc. logo

Charlotte's Web Holdings, Inc.

CWBHF

0.204 USD

Financials

Numbers are in millions USD

Numbers are in millions USD